Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Waquar uddin, Ahmed"'
Publikováno v:
Journal of the Dow University of Health Sciences, Vol 14, Iss 3 (2020)
To determine the response rate to sofosbuvir and ribavirin in chronic Hepatitis C Virus (HCV) patients who did not respond or relapsed with interferon therapy. A case series study was performed at Jinnah Postgraduate Medical Centre (JPMC), Karachi fr
Externí odkaz:
https://doaj.org/article/a24b590834ac464f8bc06732d40878b7
Publikováno v:
Journal of the Dow University of Health Sciences. 14
To determine the response rate to sofosbuvir and ribavirin in chronic Hepatitis C Virus (HCV) patients who did not respond or relapsed with interferon therapy. A case series study was performed at Jinnah Postgraduate Medical Centre (JPMC), Karachi fr
Autor:
Shaimuna Fareeha, Sajjad, Waquar uddin, Ahmed, Ambreen, Arif, Syed Ejaz, Alam, Javeria, Waquar
Publikováno v:
JPMA. The Journal of the Pakistan Medical Association. 62(11)
Recommended treatment of chronic Hepatitis C virus (HCV) infection is interferon and ribavirin. Most patients develop side effects during treatment. Weight loss is one of the side effects of interferon therapy. Present study was conducted at Pakistan
Autor:
Waquar Uddin, Ahmed, Ambreen, Arif, Huma, Qureshi, Syed Ejaz, Alam, Raheel, Ather, Shamoona, Fariha, Javeria, Waquar
Publikováno v:
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP. 21(2)
To determine factors influencing response of interferon therapy in chronic hepatitis C patients.Descriptive, analytical study.Pakistan Medical Research Centre, Jinnah Postgraduate Medical Centre, Karachi, from January 1998 to December 2009.Patients o
Publikováno v:
JPMA. The Journal of the Pakistan Medical Association. 58(12)
To study the presentation of Achalasia and compare the response of pneumatic dilatation with surgery.Retrospective analysis of patient's records (January 2000-December 2005) from outpatients department of Pakistan Medical Research Council), Jinnah Po
Publikováno v:
JPMA. The Journal of the Pakistan Medical Association. 56(3)
The objective was to see the efficacy of ursodeoxycholic acid in improving the ALT levels in patients suffering from chronic liver disease. Thirty patients suffering from chronic liver disease (either B or C) were given oral ursodeoxycholic acid in a